Yonsei University
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer
Phase 2
- Conditions
- Breast Cancer
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2010-10-29
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 49
- Registration Number
- NCT00994968
- Locations
- π°π·
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
Effect of Candesartan in Alcoholic Liver Fibrosis
Phase 1
Completed
- Conditions
- Alcoholic Liver Disease
- Interventions
- First Posted Date
- 2009-10-07
- Last Posted Date
- 2009-10-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 85
- Registration Number
- NCT00990639
- Locations
- π°π·
Yonsei University Wonju College of Medicine Wonju Christian Hospital, Wonju, Kangwon-do, Korea, Republic of
Venous Air Embolism in Cesarean Delivery, Especially Placental Previa
Completed
- Conditions
- Cesarean Delivery With Placental Previa
- Interventions
- Procedure: cesarean delivery
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2010-11-04
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 80
- Registration Number
- NCT00985764
- Locations
- π°π·
Severance Hospital, Seoul, Korea, Republic of
Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
Phase 2
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2011-10-20
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 130
- Registration Number
- NCT00985556
- Locations
- π°π·
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass
Not Applicable
Completed
- Conditions
- Mitral Valvular Heart Disease
- Interventions
- Drug: 6% hydroxyethyl starch 130/0.4 and 5% albumin
- First Posted Date
- 2009-09-17
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 36
- Registration Number
- NCT00978588
Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study
Completed
- Conditions
- Infantile Spasms
- First Posted Date
- 2009-08-28
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- Yonsei University
- Registration Number
- NCT00968136
Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 140
- Registration Number
- NCT00962676
- Locations
- π°π·
Yonsei Univ., Seoul, Korea, Republic of
Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-Ξ³ Assay
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2009-08-20
- Lead Sponsor
- Yonsei University
- Registration Number
- NCT00962793
Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2011-05-27
- Lead Sponsor
- Yonsei University
- Registration Number
- NCT00944385
- Locations
- π°π·
Severance Hospital, Seoul, Korea, Republic of
Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery
Not Applicable
Completed
- Conditions
- Cardiac Surgery
- Interventions
- Drug: rhEPO
- First Posted Date
- 2009-07-15
- Last Posted Date
- 2010-10-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 74
- Registration Number
- NCT00939978
- Locations
- π°π·
Severance hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath